New Pharmaceuticals research report from Current Partnering is now available from Fast Market Research

Boston, MA -- (ReleaseWire) -- 02/03/2014 --The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in vaccine and adjuvant partnering deals
Deal terms analysis
Partnering agreement structure
Partnering contract documents
Top deals by value
Most active dealmakers
Average deal terms for vaccines

The report provides a detailed understanding and analysis of how and why companies enter vaccine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report also includes adjuvant deals and alliances.

View Full Report Details and Table of Contents

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This report contains over 1,100 links to online copies of actual vaccine deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of vaccine dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in vaccine dealmaking since 2007, including details of average headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading vaccine deals since 2007. Deals are listed by headline value, signed by big pharma, big biotech, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of vaccine deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Companies Mentioned in this Report: Abbott Japan, Abbott Laboratories, Abraxis BioScience, ACADIA Pharmaceuticals, Acceleron Pharma, Achillion Pharmaceuticals, Adnexus Therapeutics, Adolor, AEterna Zentaris, Affymax, Agensys, Alfacell, Allergan, Ambit Biosciences, Amgen, Amylin Pharmaceuticals, Anacor Pharmaceuticals, Anesiva, Archemix, Ariad Pharmaceuticals, ArQule, Array Biopharma, ARYx Therapeutics, Astellas Pharma, AstraZeneca, Athersys, Atley Pharmaceuticals, Auriga Laboratories, Aventis, AVEO Pharmaceuticals, Barrier Therapeutics, Bayer, Biogen Idec, BioMarin Pharmaceuticals, BioMerieux, Biovail, Boehringer Ingelheim, Bristol-Myers Squibb, Cardiome Pharma, Celgene, Cell Genesys, Cepheid, ChemoCentryx, Cornerstone Biopharma, Cortex Pharmaceuticals, Critical Therapeutics, Cubist Pharmaceuticals, CV Therapeutics, Cypress Bioscience, Cytokinetics, Daiichi Sankyo, DepoMed, Dey Pharma, DoctorDirectory, DOR BioPharma, Dyax, Dynavax Technologies, Eisai, Eli Lilly, Enanta Pharmaceuticals, Endo Pharmaceuticals, Exelixis, Facet Biotechnology, Forest Laboratories, Forest Pharmaceuticals, Galderma, Genentech, Genzyme, Gilead Sciences, GlaxoSmithKline, GTx, Hyperion Therapeutics, ImmunoGen, Immunomedics, Impax Laboratories, Incyte, Inspire Pharmaceuticals, InterMune, InVentiv Health, Ipsen, Ironwood Pharmaceuticals, Janssen Research & Development, KaloBios Pharmaceuticals, La Jolla Pharmaceutical, Macrogenics, MAP Pharmaceuticals, Maxygen, Medivation, Menarini, Merck and Co, Merck KGaA, Merck Sharpe & Dohme, Merrimack Pharmaceuticals, Metabasis Therapeutics, Micromet, MiddleBrook Pharmaceutical, Millennium, Mylan Laboratories, Nektar Therapeutics, Novartis, Novartis Consumer Health, Novo Nordisk, Nycomed, OncoGenex Pharmaceuticals, Optimer Pharmaceuticals, Orexigen Therapeutics, Ortho Biotech, Par Pharmaceutical, PDL BioPharma, Pfizer, PhotoMedex, Procter & Gamble, Procter & Gamble Pharmaceuticals, Purdue Pharma, Regeneron Pharmaceuticals, Rib-X Pharmaceuticals, Roche, Sagent Pharmaceuticals, Salix Pharmaceuticals, Sanofi-Aventis, Sanofi-Pasteur, Sanofi, Santarus, Schering-Plough, Seattle Genetics, Serono, Sigma-Tau, Solvay, Somaxon Pharmaceuticals, Spectrum Pharmaceuticals, Strativa Pharmaceuticals, Sucampo Pharmaceuticals, Synta Pharmaceuticals, Takeda Pharmaceutical, TAP Pharmaceutical, Targacept, Tercica, Teva Pharmaceuticals, Tibotec, Transcept Pharmaceuticals, Ucyclyd Pharma, Valeant Pharmaceuticals, Veracyte, Vernalis, Vical, Victory Pharma, Warner Chilcott, Watson Pharmaceuticals, Wyeth, Xenoport, Zogenix, ZymoGenetics

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Cancer Vaccine Partnering Terms and Agreements
- Infectious Vaccines Partnering Terms and Agreements
- Bioinformatics Partnering Terms and Agreements
- Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
- Discovery Stage Partnering Terms and Agreements
- Personalized Medicine Partnering Terms and Agreements
- Orphan Drugs Partnering Terms and Agreements
- Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
- Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech
- Biomarker Partnering Terms and Agreements